Complete Regression of Established Subcutaneous B16 Murine Melanoma Tumors after Delivery of an HIV-1 Vpr-Expressing Plasmid by in Vivo Electroporation (Q57081536)

From Wikidata

Jump to navigation Jump to search

article

Language	Label	Description	Also known as
English	Complete Regression of Established Subcutaneous B16 Murine Melanoma Tumors after Delivery of an HIV-1 Vpr-Expressing Plasmid by in Vivo Electroporation	article

Statements

scholarly article

0 references

Complete Regression of Established Subcutaneous B16 Murine Melanoma Tumors after Delivery of an HIV-1 Vpr-Expressing Plasmid by in Vivo Electroporation (English)

0 references

electroporation

1 reference

based on heuristic

inferred from title

Karuppiah Muthumani

object named as

Karuppiah Muthumani

3

0 references

David B. Weiner

5

object named as

David B. Weiner

0 references

author name string

Andrea N. McCray

1

0 references

Kenneth E. Ugen

2

0 references

J.J. Kim

4

0 references

Richard Heller

6

0 references

publication date

November 2006

0 references

Molecular Therapy

0 references

14

0 references

5

0 references

647-655

0 references

Human immunodeficiency virus: the eighth gene

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.06.010

7 January 2021

Arginine residues in the C-terminus of HIV-1 Vpr are important for nuclear localization and cell cycle arrest

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.06.010

7 January 2021

Lentiviral delivery of HIV-1 Vpr protein induces apoptosis in transformed cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.06.010

7 January 2021

Adenovirus encoding HIV-1 Vpr activates caspase 9 and induces apoptotic cell death in both p53 positive and negative human tumor cell lines

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.06.010

7 January 2021

HIV-1 Vpr: enhancing sensitivity of tumors to apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.06.010

7 January 2021

In vitro and in vivo tumor growth suppression by HIV-1 Vpr.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.06.010

7 January 2021

Regression of subcutaneous B16 melanoma tumors after intratumoral delivery of an IL-15-expressing plasmid followed by in vivo electroporation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.06.010

7 January 2021

Specific G2 arrest of caprine cells infected with a caprine arthritis encephalitis virus expressing vpr and vpx genes from simian immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.06.010

7 January 2021

In vivo gene delivery by electroporation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.06.010

7 January 2021

DNA electrotransfer: its principles and an updated review of its therapeutic applications

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.06.010

7 January 2021

Highly efficient electro-gene therapy of solid tumor by using an expression plasmid for the herpes simplex virus thymidine kinase gene

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.06.010

7 January 2021

Intratumoral delivery of interleukin 12 expression plasmids with in vivo electroporation is effective for colon and renal cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.06.010

7 January 2021

Electroporation-enhanced gene delivery in mammary tumors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.06.010

7 January 2021

Plasmid DNA vaccines: investigation of integration into host cellular DNA following intramuscular injection in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.06.010

7 January 2021

First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.06.010

7 January 2021

Gene medicines: the end of the beginning?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.06.010

7 January 2021

IL-12 gene therapy using an electrically mediated nonviral approach reduces metastatic growth of melanoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.06.010

7 January 2021

Effective treatment of B16 melanoma by direct delivery of bleomycin using electrochemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.06.010

7 January 2021

IL-12 plasmid delivery by in vivo electroporation for the successful treatment of established subcutaneous B16.F10 melanoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.06.010

7 January 2021

Electrically mediated delivery of vector plasmid DNA elicits an antitumor effect

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.06.010

7 January 2021

Electroporation for targeted gene transfer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.06.010

7 January 2021

Immune surveillance against virus-induced tumors and nonrejectability of spontaneous tumors: contrasting consequences of host versus tumor evolution

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.06.010

7 January 2021

A critique of the evidence for active host defence against cancer, based on personal studies of 27 murine tumours of spontaneous origin

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.06.010

7 January 2021

HIV-1 Vpr induces apoptosis through caspase 9 in T cells and peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.06.010

7 January 2021

In vivo electroporation of plasmids encoding GM-CSF or interleukin-2 into existing B16 melanomas combined with electrochemotherapy induces long-term antitumour immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.06.010

7 January 2021

In vivo electroporation-mediated transfer of interleukin-12 and interleukin-18 genes induces significant antitumor effects against melanoma in mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.06.010

7 January 2021

Effect of electrically mediated intratumor and intramuscular delivery of a plasmid encoding IFN alpha on visible B16 mouse melanomas

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.06.010

7 January 2021

Antisense MBD2 gene therapy inhibits tumorigenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.06.010

7 January 2021

Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.06.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.YMTHE.2006.06.010

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57081536&oldid=2086914347"